{"cluster": 50, "subcluster": 45, "abstract_summ": " The rapidity with which antiviral monoclonal antibodies can be isolated and engineered offers an attractive alternative option for passive immunization . For over a century, transfusion of convalescent plasma from recovered individuals has been tried as a therapeutic approach when a novel pathogen emerges ."}